Novo Nordisk’s Once-Weekly Insulin Gains Superiority Finding As Lilly Advances

Novo Nordisk announced data from the ONWARDS 1 and 6 trials of insulin icodec • Source: Shutterstock

More from Alimentary/Metabolic

More from Therapy Areas